SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 77 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $6,000 | -98.3% | 48,981 | -76.1% | 0.00% | – |
| Q3 2018 | $348,000 | -25.6% | 205,005 | -23.8% | 0.00% | – |
| Q2 2018 | $468,000 | -13.8% | 269,003 | -9.3% | 0.00% | -100.0% |
| Q1 2018 | $543,000 | -16.7% | 296,444 | +1.4% | 0.00% | 0.0% |
| Q4 2017 | $652,000 | -35.1% | 292,398 | -15.6% | 0.00% | 0.0% |
| Q3 2017 | $1,004,000 | -44.0% | 346,278 | -14.1% | 0.00% | -50.0% |
| Q2 2017 | $1,792,000 | -47.2% | 402,894 | -44.7% | 0.00% | -33.3% |
| Q1 2017 | $3,395,000 | +131.4% | 728,352 | +202.3% | 0.00% | +200.0% |
| Q4 2016 | $1,467,000 | +7.3% | 240,918 | -2.9% | 0.00% | 0.0% |
| Q3 2016 | $1,367,000 | +84.2% | 248,027 | +27.1% | 0.00% | 0.0% |
| Q2 2016 | $742,000 | -4.9% | 195,140 | -30.9% | 0.00% | 0.0% |
| Q1 2016 | $780,000 | -39.0% | 282,265 | +25.3% | 0.00% | 0.0% |
| Q4 2015 | $1,278,000 | +29.4% | 225,293 | +21.0% | 0.00% | 0.0% |
| Q3 2015 | $988,000 | -40.5% | 186,255 | -6.8% | 0.00% | -50.0% |
| Q2 2015 | $1,660,000 | +288.8% | 199,916 | +116.4% | 0.00% | – |
| Q1 2015 | $427,000 | +6.0% | 92,375 | -30.1% | 0.00% | – |
| Q4 2014 | $403,000 | +8.0% | 132,059 | -1.4% | 0.00% | – |
| Q3 2014 | $373,000 | -48.6% | 133,906 | -24.9% | 0.00% | -100.0% |
| Q2 2014 | $726,000 | +5.1% | 178,386 | +37.0% | 0.00% | 0.0% |
| Q1 2014 | $691,000 | +3.6% | 130,193 | +9.9% | 0.00% | 0.0% |
| Q4 2013 | $667,000 | +61.1% | 118,479 | +30.8% | 0.00% | – |
| Q3 2013 | $414,000 | -47.7% | 90,562 | -50.6% | 0.00% | -100.0% |
| Q2 2013 | $792,000 | +97.0% | 183,357 | +177.3% | 0.00% | – |
| Q1 2013 | $402,000 | – | 66,133 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|